5-Bromopyridin-3-Yl 3-Deoxy-1-Thio-3-[4-(3,4,5-Trifluorophenyl)-1H-1,2,3-Triazol-1-Yl]-Alfa-D-Galactopyranoside

2 trials

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

1 Sponsors

3 Countries

Phase I/II

Phase I (Other)

Phase I/II: 1 Phase I (Other): 1

Indications tested

Non-small cell lung cancer 1 Non-small cell lung cancer stage IV 1 Non-small cell lung cancer stage IIIB 1

Sponsors using this IMP

Galecto Biotech AB 2

All trials

2 total

An Open-label, Randomized, Three-period, Crossover Study to compare the Pharmacokinetics of GB1211 upon dosing a capsule under fasting condi… Ended

2022-502200-67-00 Phase I (Other) 1 country Galecto Biotech AB
A clinical study to test the safety and efficacy of GB1211 in combination with atezolizumab in patients with Non-Small Cell Lung Cancer (NSC… Ended

2024-514419-93-00 Phase I/II 2 countries Galecto Biotech AB

Showing 1–2 of 2 trials

← All drugs A–Z